Patient Access Network Foundation uses the following criteria to
determine eligibility for assistance:
1. You have to be insured and your insurance has to cover the
medication for which you are seeking assistance.
2. The medication you take must fight the disease directly.
3. You have to be a US resident.
4. Your income must fall below 300% of the Federal Poverty
Level.
Click
here
for the Federal Poverty Guidelines
applications for new and renewal patients are accepted and
grants are immediately allocated.
Lung cancer is an abnormal growth of the cells in the lungs. It is the leading cause of cancer related death among both men and women in the United States. Every year, approximately 170,000 Americans are diagnosed with lung cancer. Non-small cell lung cancer metastasizes at a slower rate than small cell lung cancer and accounts for approximately 80 percent of all lung cancers.
Chemotherapy destroys lung cancer cells by impeding their growth and reproduction. Chemotherapy drugs are given by intravenous infusion or injection or by mouth. Chemotherapy is often used alone, or in conjunction with radiation therapy or surgery.
Private insurance and Medicare are the most common types of health coverage for patients with NSCLC.
Both can lead to access issues for many patients. As a result,
low-to-moderate income beneficiaries are often unable to afford the
out-of-pocket costs associated with their treatment.
